Plain-language analysis of mechanisms, evidence, regulatory status, and the actual science behind the peptide conversation.
Two short Russian-origin regulatory peptides compared on the same axes — mechanisms, intranasal pharmacokinetics, the actual clinical evidence base, and where the popular nootropic framing exceeds what controlled human data supports
2600 words · May 2026A careful mechanistic review of GHK-Cu — the copper-binding tripeptide with 50+ years of research. Redox chemistry, gene-expression footprint, what the dermal and wound data establish, and where popular framing exceeds the evidence
2500 words · May 2026An evidence-weighted look at tirzepatide safety in 2026 — what the SURPASS and SURMOUNT extensions established, the still-open questions on thyroid, pancreas, and gastric motility, and the gap between trial populations and real-world use
2400 words · May 2026A careful, non-promotional look at BPC-157 safety — animal toxicology, the structure of the human evidence gap, theoretical concerns, and how the unregulated supply chain shapes real-world risk
2300 words · May 2026How a mitochondrial-derived peptide actually works at the molecular level — AMPK activation, nuclear translocation, and what 2026 evidence does and does not support
2200 words · May 2026Mechanism, half-life, pulsatility, stacking logic, and what the 2026 evidence actually supports for these two GH peptides
1800 words · April 2026Definitions, classifications, and why peptides became one of the most-discussed health topics of the decade
2200 words · April 2026A framework for evaluating peptide safety claims, from animal models to human pharmacovigilance
2400 words · April 2026Mechanism, head-to-head data, side effects, and what the next generation of incretin peptides looks like
2100 words · April 2026What animal models show, what human data exists, and what the recovery community gets right and wrong
1900 words · April 2026Manufacturing, regulatory pathways, sterility, and how to read certificates of analysis
2000 words · April 2026A current snapshot of the regulatory landscape, the 503A and 503B pathways, and what 2026 changed
1700 words · April 2026A non-chemist guide to reading purity certificates and understanding what really matters
2500 words · April 2026A reference for the most-used vocabulary in peptide research, from agonist to zwitterion